SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Eun Hee Kim(Memorial Sloan Kettering Cancer Center), Janine O. Ilagan(Fred Hutch Cancer Center), Yang Liang(Yale Cancer Center), Gerrit M. Daubner, Stanley Chun-Wei Lee(Memorial Sloan Kettering Cancer Center), Aravind Ramakrishnan(University of Washington Medical Center), Yue Li(Yale University), Young Rock Chung(Memorial Sloan Kettering Cancer Center), Jean‐Baptiste Micol(Memorial Sloan Kettering Cancer Center), Michele E. Murphy(Fred Hutch Cancer Center), Hana Cho(Memorial Sloan Kettering Cancer Center), Min Kyung Kim(Memorial Sloan Kettering Cancer Center), Ahmad S. Zebari(Fred Hutch Cancer Center), Shlomzion Aumann(Memorial Sloan Kettering Cancer Center), Christopher Y. Park(Memorial Sloan Kettering Cancer Center), Silvia Buonamici, Peter G. Smith, H. Joachim Deeg(University of Washington Medical Center), Camille Lobry(Université Paris-Sud), Iannis Aifantis(Howard Hughes Medical Institute), Yorgo Modis(MRC Laboratory of Molecular Biology), Frédéric H.‐T. Allain, Stephanie Halene(Yale Cancer Center), Robert K. Bradley(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center)
Cancer Cell
May 1, 2015
Cited by 564Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis